Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hai Zhi Yuan (human somatropin) vs active control in idiopathic short stature children
CTR20263169Phase 3Active
- Sponsor
- Zhongshan Sinobioway Hygene Biomedicine
- Start
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in Idiopathic Short Stature (ISS), sponsored by Zhongshan Sinobioway Hygene Biomedicine. Started Aug 2026; status: active.
02
Drugs
somatropin
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on CTR20263169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263169.